|
Volumn 11, Issue 6, 2011, Pages 5340-5344
|
Detectability of Her2 positive tumors using monoclonal antibody conjugated iron oxide nanoparticles in MRI
a b c b d a |
Author keywords
USPIO; Breast cancer; Her2 neu; Herceptin; MRI contrast agent; Nanomagnetic particles
|
Indexed keywords
-USPIO;
BREAST CANCER;
HER2/NEU;
HERCEPTIN;
MRI CONTRAST AGENTS;
NANOMAGNETIC PARTICLES;
CELL MEMBRANES;
CYTOLOGY;
DISEASES;
GENE EXPRESSION;
IRON OXIDES;
MAMMALS;
MONOCLONAL ANTIBODIES;
NANOPARTICLES;
TUMORS;
SYNTHESIS (CHEMICAL);
ANTIBODY CONJUGATE;
DEXTRAN;
DIAGNOSTIC AGENT;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
HER2 PROTEIN, HUMAN;
MAGNETITE NANOPARTICLE;
MONOCLONAL ANTIBODY;
ANIMAL;
ARTICLE;
BIOSYNTHESIS;
BREAST TUMOR;
CHEMISTRY;
ENZYMOLOGY;
FEMALE;
FLUORESCENCE MICROSCOPY;
METABOLISM;
METHODOLOGY;
MOUSE;
NUCLEAR MAGNETIC RESONANCE IMAGING;
NUDE MOUSE;
TUMOR CELL LINE;
XENOGRAFT;
ANIMALS;
ANTIBODIES, MONOCLONAL;
BREAST NEOPLASMS;
CELL LINE, TUMOR;
DEXTRANS;
FEMALE;
IMMUNOCONJUGATES;
MAGNETIC RESONANCE IMAGING;
MAGNETITE NANOPARTICLES;
MICE;
MICE, NUDE;
MICROSCOPY, FLUORESCENCE;
RECEPTOR, ERBB-2;
TRANSPLANTATION, HETEROLOGOUS;
|
EID: 80051766866
PISSN: 15334880
EISSN: 15334899
Source Type: Journal
DOI: 10.1166/jnn.2011.3775 Document Type: Conference Paper |
Times cited : (28)
|
References (10)
|